Tildren Injection
Category: Treatment for bone-related lameness including Navicular Disease and Bone Spavin.
Product Description: Tildren is a tiludronic acid injection formulated for the management of lameness linked to bone changes.
Indication: Used in horses for conditions such as Navicular Disease and Bone Spavin, often alongside corrective shoeing.
Administration and Dosage:
• 0.1 mg/kg IV once daily for 10 days (10 mL per 500 kg).
• Dilute into a 1 L infusion bag of 0.9% Sodium Chloride or 5% Glucose; infuse over 30 minutes.
Key Benefits
• Targets bone-related lameness.
• Effective in Navicular Disease and Bone Spavin.
• Can be combined with corrective shoeing for improved outcomes.
• Effective in Navicular Disease and Bone Spavin.
• Can be combined with corrective shoeing for improved outcomes.
Size
50 mL
Target Animals
Horses
Safety
Administer only by slow IV infusion. Users must adhere to local and racing regulations.
